Skip to main content
Signal8

Gryaznov Sergei

SEC insider (Form 3/4/5 filer). CIK 0001913228. Chief Scientific Officer at MAIA Biotechnology, Inc. (MAIA). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in CHICAGO, IL.

Companies Gryaznov Sergei has filed insider reports for

  • MAIA Biotechnology, Inc. (MAIA): Officer, Chief Scientific Officer
Gryaznov Sergei profile photo

Gryaznov Sergei

CIK: 0001913228

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MAIA Biotechnology, Inc. logo
MAIA

MAIA Biotechnology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • MAIA Biotechnology, Inc. logo
    MAIA

    MAIA Biotechnology, Inc.

    Jun 1, 2026
    Purchase
    Direct
    2K shares at avg. $1.34$3K
  • MAIA Biotechnology, Inc. logo
    MAIA

    MAIA Biotechnology, Inc.

    May 29, 2026
    Award

    Stock Options

    Direct
    400K shares-
  • MAIA Biotechnology, Inc. logo
    MAIA

    MAIA Biotechnology, Inc.

    Apr 10, 2026
    Award

    Stock Options

    Direct
    400K shares-
  • MAIA Biotechnology, Inc. logo
    MAIA

    MAIA Biotechnology, Inc.

    May 14, 2025
    Award

    Stock Options

    Direct
    200K shares-
  • MAIA Biotechnology, Inc. logo
    MAIA

    MAIA Biotechnology, Inc.

    Feb 10, 2025
    Award

    Stock Options

    Direct
    200K shares-

1-5 of 5